Endometrial Cancer Genomics
- Cancer PHGKB -
What's New
Last Posted: Feb 07, 2019
- Comprehensive Paired Tumor/Germline Testing for Lynch Syndrome: Bringing Resolution to the Diagnostic Process.
Salvador Monalyn U et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2019 Jan JCO1800696 - Recent advances in Lynch syndrome.
Biller Leah H et al. Familial cancer 2019 Jan - Cancer susceptibility gene mutations in type I and II endometrial cancer.
Long Beverly et al. Gynecologic oncology 2019 Jan 152(1) 20-25 - The role of biomarkers in endometrial cancer and hyperplasia: a literature review.
Hutt Suzanna et al. Acta oncologica (Stockholm, Sweden) 2019 Jan 1-11 - [Expression and clinical significance of MMR protein and MLH1 promoter methylation testing in endometrial cancer].
Jin W et al. Zhonghua fu chan ke za zhi 2018 Dec 53(12) 823-830 - [Lynch syndrome: What is new?]
Pellat Anna et al. Bulletin du cancer 2018 Dec - Multicenter experience with large panel next-generation sequencing in patients with advanced solid cancers in Japan.
Kato Shingo et al. Japanese journal of clinical oncology 2018 Dec - Liquid Biopsy in Endometrial Cancer: New Opportunities for Personalized Oncology.
Muinelo-Romay Laura et al. International journal of molecular sciences 2018 Aug 19(8) - [Diagnosis and Treatment of MSI-H Cancer in Gynecological Cancer].
Yamamoto Nao et al. Gan to kagaku ryoho. Cancer & chemotherapy 2018 Nov 45(11) 1577-1581 - Minimal microsatellite shift in microsatellite instability high endometrial cancer: a significant pitfall in diagnostic interpretation.
Wu Xinyu et al. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2018 Nov
No hay comentarios:
Publicar un comentario